MX2022012360A - Tratamiento. - Google Patents
Tratamiento.Info
- Publication number
- MX2022012360A MX2022012360A MX2022012360A MX2022012360A MX2022012360A MX 2022012360 A MX2022012360 A MX 2022012360A MX 2022012360 A MX2022012360 A MX 2022012360A MX 2022012360 A MX2022012360 A MX 2022012360A MX 2022012360 A MX2022012360 A MX 2022012360A
- Authority
- MX
- Mexico
- Prior art keywords
- treatment
- viral infections
- compositions
- niclosamide
- aerosols
- Prior art date
Links
- 239000000203 mixture Substances 0.000 abstract 2
- 239000002202 Polyethylene glycol Substances 0.000 abstract 1
- 206010062106 Respiratory tract infection viral Diseases 0.000 abstract 1
- 208000036142 Viral infection Diseases 0.000 abstract 1
- 239000000443 aerosol Substances 0.000 abstract 1
- RJMUSRYZPJIFPJ-UHFFFAOYSA-N niclosamide Chemical compound OC1=CC=C(Cl)C=C1C(=O)NC1=CC=C([N+]([O-])=O)C=C1Cl RJMUSRYZPJIFPJ-UHFFFAOYSA-N 0.000 abstract 1
- 229960001920 niclosamide Drugs 0.000 abstract 1
- 229920001223 polyethylene glycol Polymers 0.000 abstract 1
- 230000002685 pulmonary effect Effects 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 230000009385 viral infection Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
- A61K31/609—Amides, e.g. salicylamide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/40—Cyclodextrins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Virology (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Otolaryngology (AREA)
- Pulmonology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Inorganic Chemistry (AREA)
- Molecular Biology (AREA)
- Dispersion Chemistry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pain & Pain Management (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Mechanical Treatment Of Semiconductor (AREA)
- Crystals, And After-Treatments Of Crystals (AREA)
- Polarising Elements (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Composiciones inhalables que comprenden niclosamida, o una sal farmacéuticamente aceptable de la misma, y polietilenglicol; aerosoles de las composiciones; y las administraciones pulmonares para su uso en el tratamiento de infecciones víricas, por ejemplo, infecciones víricas respiratorias.
Applications Claiming Priority (8)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB2004844.3A GB202004844D0 (en) | 2020-04-01 | 2020-04-01 | Treatment |
GBGB2005340.1A GB202005340D0 (en) | 2020-04-09 | 2020-04-09 | Formulation |
GBGB2010575.5A GB202010575D0 (en) | 2020-07-09 | 2020-07-09 | Treatment |
GBGB2010573.0A GB202010573D0 (en) | 2020-07-09 | 2020-07-09 | Formulation |
GBGB2016274.9A GB202016274D0 (en) | 2020-10-14 | 2020-10-14 | Formulation |
GBGB2016289.7A GB202016289D0 (en) | 2020-10-14 | 2020-10-14 | Treatment |
GBGB2103957.3A GB202103957D0 (en) | 2021-03-22 | 2021-03-22 | Treatment |
PCT/EP2021/058046 WO2021198115A1 (en) | 2020-04-01 | 2021-03-26 | Treatment |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2022012360A true MX2022012360A (es) | 2022-10-21 |
Family
ID=75302583
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2022012360A MX2022012360A (es) | 2020-04-01 | 2021-03-26 | Tratamiento. |
Country Status (11)
Country | Link |
---|---|
US (1) | US20230147683A1 (es) |
EP (1) | EP4125804A1 (es) |
JP (1) | JP2023520542A (es) |
KR (1) | KR20230020952A (es) |
CN (1) | CN115701984A (es) |
AU (1) | AU2021248603A1 (es) |
BR (1) | BR112022019519A2 (es) |
CA (1) | CA3173163A1 (es) |
IL (1) | IL296898A (es) |
MX (1) | MX2022012360A (es) |
WO (1) | WO2021198115A1 (es) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2022169373A1 (en) * | 2021-02-04 | 2022-08-11 | Alan Moana Alexander | Niclosamide compositions having improved bioavailability |
GB202102488D0 (en) * | 2021-02-22 | 2021-04-07 | Union Therapeutics As | Treatment |
CN113908121B (zh) * | 2021-10-13 | 2023-03-28 | 中国农业科学院上海兽医研究所(中国动物卫生与流行病学中心上海分中心) | 一种氯硝柳胺注射液及其制备和应用 |
WO2023183557A1 (en) * | 2022-03-25 | 2023-09-28 | Neurelis, Inc. | Intranasal olanzapine formulations and methods of their use |
KR20240032430A (ko) * | 2022-09-02 | 2024-03-12 | 주식회사 스카이테라퓨틱스 | 니클로사미드의 신규 염, 이의 분자회합체 및 이를 포함하는 약학 조성물 |
Family Cites Families (56)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19953317C1 (de) | 1999-11-05 | 2001-02-01 | Pari Gmbh | Inhalationsvernebler |
DE10004465A1 (de) | 2000-02-02 | 2001-08-16 | Pari Gmbh | Inhalationsvernebler |
DE10022795B4 (de) | 2000-05-10 | 2005-04-14 | Pari GmbH Spezialisten für effektive Inhalation | Atemgesteuertes Inhalationstherapiegerät |
DE10040528A1 (de) | 2000-08-18 | 2002-02-28 | Pari Gmbh | Inhalationsvorrichtung und Verfahren zur Erzeugung eines Partikelnebels für Inhalationszwecke |
DE10102846B4 (de) | 2001-01-23 | 2012-04-12 | Pari Pharma Gmbh | Aerosolgenerator |
DE50102690D1 (de) | 2001-10-18 | 2004-07-29 | Pari Gmbh | Inhalationstherapievorrichtung |
DE50106644D1 (de) | 2001-10-18 | 2005-08-04 | Pari Gmbh | Inhalationstherapievorrichtung |
DE10229889A1 (de) | 2002-07-03 | 2004-01-29 | Pari GmbH Spezialisten für effektive Inhalation | Inhalationstherapievorrichtung |
EP1386672B1 (en) | 2002-08-02 | 2010-04-07 | PARI Pharma GmbH | Fluid droplet production apparatus |
DE10239321B3 (de) | 2002-08-27 | 2004-04-08 | Pari GmbH Spezialisten für effektive Inhalation | Aerosoltherapievorrichtung |
DE10243371B4 (de) | 2002-09-18 | 2006-06-14 | Pari GmbH Spezialisten für effektive Inhalation | Aeorosoltherapiegerät |
DE10250625A1 (de) | 2002-10-30 | 2004-05-19 | Pari GmbH Spezialisten für effektive Inhalation | Inhalationstherapievorrichtung |
DE10251864B3 (de) | 2002-11-07 | 2004-06-24 | Pari GmbH Spezialisten für effektive Inhalation | Inhalationstherapievorrichtung |
DE10251865B3 (de) | 2002-11-07 | 2004-05-13 | Pari GmbH Spezialisten für effektive Inhalation | Inhalationstherapievorrichtung |
DE10257381B4 (de) | 2002-12-09 | 2006-09-14 | Pari GmbH Spezialisten für effektive Inhalation | Inhalationstherapievorrichtung |
DE10320143A1 (de) | 2003-05-06 | 2004-12-16 | Pari GmbH Spezialisten für effektive Inhalation | Vernebleranschlussvorrichtung für Beatmungsgeräte oder dergleichen |
TWI343810B (en) * | 2003-05-28 | 2011-06-21 | Nat Health Research Institutes | A pharmaceutical composition for inhibiting coronavirus |
DE10345950A1 (de) | 2003-10-02 | 2005-05-19 | Pari GmbH Spezialisten für effektive Inhalation | Inhalationstherapievorrichtung mit Ventil |
DE10347994A1 (de) | 2003-10-15 | 2005-06-16 | Pari GmbH Spezialisten für effektive Inhalation | Wässrige Aerosol-Zubereitung |
DE10348237A1 (de) | 2003-10-16 | 2005-05-19 | Pari GmbH Spezialisten für effektive Inhalation | Inhalationstherapievorrichtung mit einem Düsenvernebler |
DE102005006372B4 (de) | 2005-02-11 | 2007-11-29 | Pari GmbH Spezialisten für effektive Inhalation | Inhalationstherapievorrichtung und Verfahren zu deren Betrieb |
DE102005006374B3 (de) | 2005-02-11 | 2006-07-20 | Pari GmbH Spezialisten für effektive Inhalation | Aerosolerzeugungsvorrichtung und Inhalationstherapiegerät mit einer derartigen Vorrichtung |
EP1712220A1 (en) | 2005-04-15 | 2006-10-18 | PARI GmbH Spezialisten für effektive Inhalation | Pharmaceutical aerosol composition |
DE102005024779B4 (de) | 2005-05-31 | 2008-02-21 | Pari GmbH Spezialisten für effektive Inhalation | Atemzuggesteuerte Inhalationstherapievorrichtung |
DE102005038619A1 (de) | 2005-08-16 | 2007-02-22 | Pari GmbH Spezialisten für effektive Inhalation | Inhalationstherapievorrichtung mit einer Ampulle für die Bevorratung eines zu vernebelnden Medikaments |
CA2641872A1 (en) | 2006-02-09 | 2007-08-16 | Kamada Ltd. | Alpha-i antitrypsin for treating exacerbation episodes of pulmonary diseases |
DE102006017002B3 (de) | 2006-04-11 | 2007-01-11 | Pari GmbH Spezialisten für effektive Inhalation | Inhalationstherapievorrichtung mit mehrfachen Düsen |
DE102007012804A1 (de) | 2007-03-16 | 2008-09-25 | Pari Pharma Gmbh | Aerosolgenerator |
DE102008022987A1 (de) | 2008-05-09 | 2009-11-12 | Pari Pharma Gmbh | Vernebler für Beatmungsmaschinen und Beatmungsmaschine mit einem solchen Vernebler |
DE102008054431B3 (de) | 2008-12-09 | 2010-06-17 | Pari Pharma Gmbh | Aerosoltherapievorrichtung |
DE102009001037B4 (de) | 2009-02-20 | 2013-02-21 | Pari Pharma Gmbh | Inhalationstherapievorrichtung |
US9717867B2 (en) | 2009-02-27 | 2017-08-01 | Pari GmbH Spezialisten für effektive Inhalation | Method for operating an aerosol inhalation device and aerosol inhalation device |
DE102009026636B4 (de) | 2009-06-02 | 2011-04-14 | Pari Pharma Gmbh | Verfahren zum Verschweißen einer Membran mit einem Träger bei der Herstellung eines Membranverneblers |
EP2380618A1 (en) | 2010-04-26 | 2011-10-26 | PARI Pharma GmbH | Operating method for an aerosol delivery device and aerosol delivery device |
EP2457609A1 (en) | 2010-11-24 | 2012-05-30 | PARI Pharma GmbH | Aerosol generator |
US9975136B2 (en) | 2011-06-08 | 2018-05-22 | Pari Pharma Gmbh | Aerosol generator |
DE102011079810B4 (de) | 2011-07-26 | 2013-04-04 | Pari Pharma Gmbh | Einwegampulle zum Einsetzen in einen Aerosolerzeuger |
EP2708219A1 (en) | 2012-09-12 | 2014-03-19 | PARI Pharma GmbH | Opening element for opening an ampoule in an aerosol generation device and aerosol generation device comprising the opening element |
EP2735328A1 (en) | 2012-11-27 | 2014-05-28 | PARI Pharma GmbH | Fluid reservoir for an aerosol generation device, combination of fluid reservoir and primary fluid package, and aerosol generation device for use with the fluid reservoir |
EP2883564A1 (en) | 2013-12-16 | 2015-06-17 | PARI Pharma GmbH | Aerosol delivery device and method of operating the aerosol delivery device |
EP2910268A1 (en) | 2014-02-25 | 2015-08-26 | PARI Pharma GmbH | Inhalator and inhalator set |
US10583221B2 (en) * | 2014-05-12 | 2020-03-10 | Gholam A. Peyman | Method of corneal transplantation or corneal inlay implantation with cross-linking |
EP2957349A1 (en) | 2014-06-20 | 2015-12-23 | PARI Pharma GmbH | Aerosol generator and aerosol delivery device comprising the aerosol generator |
DE102014215064A1 (de) | 2014-07-31 | 2016-02-04 | Pari GmbH Spezialisten für effektive Inhalation | Vernebler |
EP2987520A1 (en) | 2014-08-18 | 2016-02-24 | PARI Pharma GmbH | Fluid reservoir for an aerosol generator and aerosol generator comprising the fluid reservoir |
EP3338783B1 (en) | 2014-09-12 | 2024-01-24 | UNION therapeutics A/S | Antibacterial use of halogenated salicylanilides |
EP3037120A1 (en) | 2014-12-23 | 2016-06-29 | PARI Pharma GmbH | Aerosol delivery device and operating method for the aerosol delivery device |
EP3127616B1 (en) | 2015-08-03 | 2017-10-18 | PARI Pharma GmbH | Method of manufacturing a vibratable head for an aerosol generator and vibratable head for an aerosol generator |
GB201604484D0 (en) | 2016-03-16 | 2016-04-27 | Antibiotx Aps And Københavns Uni University Of Copenhagen | Topical antibacterial compositions |
US11491123B2 (en) * | 2016-06-23 | 2022-11-08 | Health Research, Inc. | Pharmaceutical compositions with antiflaviviral activity |
EP3375473A1 (en) | 2017-03-17 | 2018-09-19 | PARI Pharma GmbH | Control device for aerosol nebulizer system |
WO2018173069A1 (en) * | 2017-03-21 | 2018-09-27 | Novalead Pharma Inc. | Therapeutic agent for phosphodiesterase inhibition and its related disorders |
GB201713653D0 (en) * | 2017-08-24 | 2017-10-11 | Antibiotx As | Dosage regimen |
WO2019115771A1 (en) | 2017-12-15 | 2019-06-20 | Pari Pharma Gmbh | Nebuliser system, holding system, combination comprising nebuliser system and holding system, and aerosol administration method |
EP3556475A1 (en) | 2018-04-20 | 2019-10-23 | PARI GmbH Spezialisten für effektive Inhalation | Controller for an aerosol generator |
CN110833623A (zh) * | 2019-12-20 | 2020-02-25 | 沈阳药科大学 | 氯硝柳胺乙醇胺盐-羟丙基-β-环糊精包合物及其制备 |
-
2021
- 2021-03-26 EP EP21715582.9A patent/EP4125804A1/en not_active Withdrawn
- 2021-03-26 WO PCT/EP2021/058046 patent/WO2021198115A1/en unknown
- 2021-03-26 CA CA3173163A patent/CA3173163A1/en active Pending
- 2021-03-26 IL IL296898A patent/IL296898A/en unknown
- 2021-03-26 AU AU2021248603A patent/AU2021248603A1/en active Pending
- 2021-03-26 BR BR112022019519A patent/BR112022019519A2/pt not_active Application Discontinuation
- 2021-03-26 JP JP2022560369A patent/JP2023520542A/ja active Pending
- 2021-03-26 US US17/995,079 patent/US20230147683A1/en active Pending
- 2021-03-26 KR KR1020227038248A patent/KR20230020952A/ko unknown
- 2021-03-26 CN CN202180036954.6A patent/CN115701984A/zh active Pending
- 2021-03-26 MX MX2022012360A patent/MX2022012360A/es unknown
Also Published As
Publication number | Publication date |
---|---|
BR112022019519A2 (pt) | 2022-11-16 |
WO2021198115A1 (en) | 2021-10-07 |
JP2023520542A (ja) | 2023-05-17 |
US20230147683A1 (en) | 2023-05-11 |
IL296898A (en) | 2022-12-01 |
CN115701984A (zh) | 2023-02-14 |
CA3173163A1 (en) | 2021-10-07 |
AU2021248603A1 (en) | 2022-11-10 |
KR20230020952A (ko) | 2023-02-13 |
EP4125804A1 (en) | 2023-02-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2022012360A (es) | Tratamiento. | |
MY196599A (en) | Pharmaceutical compositons comprising n-(3,5-dimethoxyphenyl)-n'-(1-methylethyl)-n-[3-(1-methyl-1h-pyrazol-4-yl)quinoxalin-6-yl]ethane-1,2-diamine | |
PH12020551709A1 (en) | Antiviral immunotropic agent for the treatment of acute respiratory viral infections | |
MX2022012359A (es) | Formulacion. | |
BRPI0707904A8 (pt) | Disfarce gustativo de fluoroquinolonas aerossolizadas | |
MX2020006740A (es) | Administracion pulsada de oxido nitrico inhalado para el tratamiento de la hipertension pulmonar. | |
MY196072A (en) | Liquid Inhalation Formulation Comprising RPL554 | |
TR201000680A2 (tr) | Tiotropyum, formoterol ve budesonid içeren farmasötik bileşimler | |
WO2014016548A3 (en) | Pharmaceutical composition comprising olodaterol and one or more further active pharmaceutical ingredient | |
TR201000681A2 (tr) | İnhalasyon yoluyla alınan kuru toz formülasyonları. | |
PH12019500083A1 (en) | Combination of ceftibuten and clavulanic acid for use in the treatment of bacterial infections | |
MX2021012708A (es) | Formulaciones novedosas que comprenden melflufen. | |
CR20210156A (es) | Administración sostenida de polipéptidos similares a la angiopoyetina 3 | |
AR100368A1 (es) | Tratamiento de trastornos respiratorios | |
EP4117704A4 (en) | CXCR4 INHIBITORS FOR THE TREATMENT OF ACUTE RESPIRATORY DISTRESS SYNDROME AND VIRUS INFECTIONS | |
WO2020176801A9 (en) | Amniotic fluid-derived extracellular vesicles and uses thereof for wound healing | |
PH12018502521A1 (en) | Beta-hairpin peptidomimetic with elastase inhibitory activity and aerosol dosage forms thereof | |
MY184654A (en) | Novel dosage form and formulation of abediterol | |
MX2021010144A (es) | Formulaciones farmaceuticas. | |
MX2019000651A (es) | Metodo y sistema para suministro de medicamento en aerosol. | |
MX2022006940A (es) | Composiciones farmaceuticas. | |
MX2018013475A (es) | Acido carboxilico para tratar/prevenir congestion nasal. | |
WO2018065917A3 (en) | A synthetic pulmonary surfactant composition for treating lung conditions | |
Gupta | Surgical masks vs. N95 respirator masks for protecting health care professionals | |
AU2021901731A0 (en) | Inhalation formulation for the treatment of respiratory viral infections |